首页> 外文期刊>Clinical and experimental pharmacology & physiology >Micro RNA RNA ‐645 promotes metastasis of osteosarcoma via targeting tumor suppressor NM NM 23 nucleoside diphosphate kinase 2
【24h】

Micro RNA RNA ‐645 promotes metastasis of osteosarcoma via targeting tumor suppressor NM NM 23 nucleoside diphosphate kinase 2

机译:微RNA RNA -645通过靶向肿瘤抑制器NM NM 23核苷二磷酸激酶2促进骨肉瘤的转移

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Summary Osteosarcoma is the most common non‐hematological primary bony malignancy in children and young adults with tumor metastasis being a common event at diagnosis. Understanding the pathogenesis of metastatic osteosarcoma may help identify potential therapeutic targets. In this study, we found that the level of microRNA‐645 (miR‐645) in osteosarcoma tumor tissues was significantly increased compared with their paired non‐tumorous tissues, and was associated with histologic grade, TNM staging, lymph metastasis and distant metastasis. Knockdown of miR‐645 caused a remarkable inhibition of migration of osteosarcoma U2 OS cells. Furthermore, miR‐645 inhibited NME 2 (nucleoside diphosphate kinase 2) expression through directly binding to its 3′ untranslated region. In human osteosarcoma tissues, we also found that NME 2 was significantly decreased in tumor tissues, and its level was negatively correlated with miR‐645. In addition, silencing NME 2 attenuated the decreased cell migration by knockdown of miR‐645, suggesting that it was involved in the miR‐645 induced cell migration of osteosarcoma cells. Taken together, we found that miR‐645 was up‐regulated in osteosarcoma tissues and could promote osteosarcoma cell migration through directly inhibiting the tumor suppressor NME 2. Our data provide novel insight into the role of miR‐645 in osteosarcoma and indicate that miR‐645 might be a potential therapeutic target of osteosarcoma.
机译:综述骨肉瘤是儿童和年轻成年人中最常见的非血液原代恶性肿瘤,肿瘤转移是诊断的常见事件。理解转移性骨肉瘤的发病机制可能有助于识别潜在的治疗靶标。在这项研究中,与其成对的非肿瘤组织相比,我们发现骨肉瘤肿瘤组织中的微躯体瘤肿瘤组织中的microRNA-645(miR-645)水平显着增加,并且与组织学级,TNM分期,淋巴转离症和远处转移相关。 MIR-645的敲低导致骨肉瘤U2 OS细胞的迁移显着抑制。此外,MiR-645通过直接结合其3'未转换区域抑制NME 2(核苷二磷酸激酶2)表达。在人骨瘤组织中,我们还发现肿瘤组织中NME 2显着降低,其水平与miR-645负相关。此外,沉默的NME 2通过敲低miR-645衰减细胞迁移,表明它涉及骨肉瘤细胞的miR-645诱导的细胞迁移。我们发现,我们发现miR-645在骨肉瘤组织中上调,可以通过直接抑制肿瘤抑制态抑制肿瘤2,促进骨肉瘤细胞迁移。我们的数据为MiR-645在骨肉瘤中的作用提供了新的洞察力,并表明mir- 645可能是骨肉瘤的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号